skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I noticed from GUD.TO's quarterly results that it does a lot of financing ativity, which make me wonder whether this is a pharmaceutical company or rather a financial firm. Don't know why its debt financing interest is so high (15%). Also please comment on its quarterly results.

Manny thanks!
Read Answer Asked by Dong Sheng on May 13, 2015
Q: i was looking to get into the stock on a pull back after it's big run. it has pull back quite a bite does this make it a good buying opportunity or is there something else going on with the stock
Read Answer Asked by garfield on May 13, 2015
Q: Peter, what your thoughts are on DexCom - DXCM-US -, more than double in a year and 6 times in 5? Thanks
Read Answer Asked by Ray on May 10, 2015
Q: Healthcare makes up 7% of one of my portfolios, and I want to increase this to 10%. It consists of 5 stocks: CXR (2.3%), DR (2.2%), and CCT, GUD, and PHM each less than 1%, and all in a non-registered account. Eventually I need to replace CCT since it has been taken over.

I have been looking to add from the following companies: CPH, CRH, CXR, GUD, PHM, PLI, and RX.

I can hold for 5 years and can tolerate some risk. Please help me figure out what stocks I should acquire to diversify within the sector to bring my weighting up to 10%, and explain why. I have room in my TFSA, so some additions could be in that account if you feel they are better placed in that account.

Thanks,
Paul J

Read Answer Asked by Paul on May 08, 2015
Q: Any reasons you know of for the drop in price of GUD in the last month?
Read Answer Asked by Jim on May 05, 2015
Q: I have started building a position in this fund in my RIF-type account mainly for an income stream as I am retired. Although it is small, it has the major healthcare companies in its portfolio.

Is this the type of fund which you would add to, working toward a full allocation of +/- 5%?

Thanks...
Read Answer Asked by Ronald on May 01, 2015
Q: I am a bit perplexed with CRH's share price performance post what seemed like a very strong quarter. The Company reported in line with consensus estimates yet the share price has lagged its peers? What are your updated views of CRH? Have you met management? Thoughts on the business and stock would be greatly appreciated. Is this a name you would consider picking up coverage of?
Read Answer Asked by Sasha on April 29, 2015
Q: PHM ANNOUNCES EXECUTION OF LETTER OF INTENT TO ACQUIRE A NATIONAL BUSINESS HEADQUARTERED IN THE SOUTHEAST WITH $40 MILLION IN ANNUALIZED REVENUE AND $13 MILLION IN ANNUALIZED ADJUSTED EBITDA

Q: IS THIS GOOD ? ARE THEY GETTING AHEAD OF THEMSELVES ? CHEWING OFF MORE THEN THEY CAN EAT?
OR HAVE THEY THE CAPACITY TO INTEGRATE SO MUCH SO FAST
THANKS
Read Answer Asked by JOSEPH on April 29, 2015
Q: There seems to be a lot of interest in this company from subscribers and I suspect this company has a lot of coverage by institutions and professional investors. My question is, if that is the case, is this a company that retail investors should invest in? What edge can they have? It seems to me that one would only want to invest in small or micro cap companies if one stood a good chance of making outsized gains. That typically means buying these companies before they get noticed.
Read Answer Asked by Murray on April 29, 2015
Q: Do you still expect modest growth from PFE into 2016? What might the impact of the strong US$ be on earnings and results? I have held it for several years for the dividend mainly. I would like to buy WSP instead and know this is apples to almonds, still....your opinion please and thank you.
Read Answer Asked by Gayle on April 28, 2015
Q: Hi Peter and team. As always I value your opinion. Presently I have the following health/bio stocks. GILD (US),XLV (US), GUD,PHM,CPH,CXR = 8% of my portfolio. I have just added CPH + CXR.Unfortunately both of them seem to be correcting as of late.
Questions:
(a) would you swap/change any of the present holdings or %
(b) Is the sector overbought and correcting or?
Read Answer Asked by Terence on April 28, 2015
Q: I see today that Credential Direct has listed Knight Therapeutics(GUD) as bearish in todays alerts. todays's closing was 7.75. and Credential alert is 5.10 - 5.60. Would you recommend selling at this point or holding. Thanks. Ernie
Read Answer Asked by Ernie on April 28, 2015
Q: I'm wondering what's happening to Valiant.The company seems to be silent, and the stock is tumbling.
Read Answer Asked by Bill on April 27, 2015
Q: Just reviewed your question with Interest dated April 24/15. Why is there so much volatility here, and seems to be on a downward spiral ever since the last high.
Can you please provide a detailed explanation.
Also I believe earning report in coming up in Mid May
Thanks
Rick
Read Answer Asked by Rick on April 27, 2015
Q: Hi guys,

I've been noticing that healthcare stocks are all down big today and part of last week. Names like Concordia, Actavis, Biogen, and smaller names like Nobilis, Patient Home and Convalo are down as well. Is this part of a sector rotation with people rotating out of a hot sector maybe to get exposure to energy with the recent run up in oil?

Thanks,
Jason
Read Answer Asked by Jason on April 27, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!